Tango Therapeutics (TNGX) director receives RSU and option grants as board compensation
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Tango Therapeutics director Lee Sung received new equity awards as part of board compensation. On April 29, 2026, Sung was granted 12,300 restricted stock units, each representing one share of common stock. These RSUs vest in three equal annual installments on January 2, 2027, January 2, 2028, and January 2, 2029, contingent on continued board service.
Sung was also granted an option for 5,200 shares of common stock at an exercise price of $22.06 per share. This option vests in 36 substantially equal monthly installments over three years starting January 2, 2026, subject to continued service. Following the grants, Sung holds 22,300 shares of common stock directly and 5,200 stock options, reflecting routine non-employee director compensation rather than open-market trading.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Lee Sung
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 5,200 | $0.00 | -- |
| Grant/Award | Common Stock | 12,300 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 5,200 shares (Direct, null);
Common Stock — 22,300 shares (Direct, null)
Footnotes (1)
- These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments on January 2, 2027, January 2, 2028 and January 2, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. The RSUs were granted in connection with the Reporting Person's service on the Issuer's board of directors and reflect the value the Reporting Person is entitled to pursuant to the Issuer's Non-Employee Director Compensation Policy. This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years commencing on January 2, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. The options were granted in connection with the Reporting Person's service on the Issuer's board of directors and reflect the value the Reporting Person is entitled to pursuant to the Issuer's Non-Employee Director Compensation Policy.
Key Figures
RSUs granted: 12,300 units
Option shares granted: 5,200 shares
Option exercise price: $22.06 per share
+3 more
6 metrics
RSUs granted
12,300 units
Restricted stock units granted on April 29, 2026
Option shares granted
5,200 shares
Stock option covering common stock granted April 29, 2026
Option exercise price
$22.06 per share
Exercise price for 5,200-share stock option
Shares after RSU grant
22,300 shares
Total common stock directly held following RSU grant
RSU vesting dates
January 2, 2027/2028/2029
Three equal annual RSU vesting installments
Option expiration
April 29, 2036
Expiration date of the 5,200-share stock option
Key Terms
restricted stock units (the "RSUs"), Non-Employee Director Compensation Policy, Stock Option (Right to Buy), exercise price, +1 more
5 terms
restricted stock units (the "RSUs") financial
"These shares are represented by restricted stock units (the "RSUs")."
Non-Employee Director Compensation Policy financial
"reflect the value the Reporting Person is entitled to pursuant to the Issuer's Non-Employee Director Compensation Policy."
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price": "22.0600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"will vest in three substantially equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What equity awards did Tango Therapeutics (TNGX) director Lee Sung receive?
Lee Sung received 12,300 restricted stock units and a stock option for 5,200 shares at $22.06 per share. Both awards are tied to Sung’s continued service on Tango Therapeutics’ board under the company’s Non-Employee Director Compensation Policy.
How do Lee Sung’s 12,300 RSUs at Tango Therapeutics (TNGX) vest?
The 12,300 RSUs vest in three substantially equal annual installments on January 2, 2027, January 2, 2028 and January 2, 2029. Each unit converts into one share of common stock, provided Sung remains in continuous service with Tango Therapeutics through each vesting date.
What are the terms of Lee Sung’s 5,200 Tango Therapeutics (TNGX) stock options?
The stock option covers 5,200 shares of common stock at a $22.06 exercise price. It vests in 36 substantially equal monthly installments over three years beginning January 2, 2026, conditioned on Sung’s continued service on Tango Therapeutics’ board of directors.
Is Lee Sung’s Form 4 transaction at Tango Therapeutics (TNGX) a market buy or sell?
The filing reports compensation-related awards, not market trades. Lee Sung acquired 12,300 RSUs and an option for 5,200 shares as grants for board service, with no cash paid and no open-market purchase or sale activity reported in this Form 4.
Why did Tango Therapeutics (TNGX) grant RSUs and options to director Lee Sung?
The RSUs and options were granted in connection with Sung’s service on Tango Therapeutics’ board. The awards reflect the value Sung is entitled to under the company’s Non-Employee Director Compensation Policy, aligning director compensation with long-term shareholder interests through equity.